Johnson & Johnson(JNJ)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
JNJ | 618.09 B | 30.42x | 6.60% | 21.48% | $8.43 | 25.74% | 0.58x | 2.03% | $281.07 | $182.94 |
LLY | 1.04 T | 39.58x | 47.70% | 33.53% | $29.55 | 102.29% | 1.62x | 0.56% | $1292.65 | $778.94 |
ABBV | 481.40 B | 77.61x | 10.20% | 9.80% | $3.51 | - | - | 2.63% | $269.39 | $189.40 |
MRK | 351.28 B | 114.82x | 5.10% | 4.77% | $1.24 | 6.96% | 1.28x | 2.31% | $156.00 | $79.67 |
AZN | 246.25 B | 23.77x | 6.40% | 17.02% | $6.68 | 21.97% | 0.64x | 2.05% | $210.52 | $153.41 |
NVO | 127.55 B | 9.69x | 2.10% | 35.35% | $3.94 | 59.82% | 0.63x | 31.28% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Johnson & Johnson (JNJ) compared to its primary competitors (including LLY, ABBV, MRK) reveals distinct metrics. JNJ trades at a valuation discount relative to its competitors, with a P/E ratio of 30.4x versus the peer average of 50.8x (representing a 40% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, JNJ's revenue growth of 6.6% lags behind the peer average of 12.5%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 21.5% compared to the peer average of 18.1%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• JNJ ranks #2 in P/E ratio, #3 in revenue growth, and #2 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-08 | $256.22 | $257.80 | $251.95 | $256.48 | 6,172,800 | -0.76% |
| 2026-10-07 | $256.21 | $260.68 | $255.73 | $258.45 | 5,402,200 | +1.44% |
| 2026-10-06 | $254.15 | $255.48 | $251.17 | $254.78 | 5,661,000 | +0.73% |
| 2026-10-05 | $256.00 | $256.24 | $252.51 | $252.93 | 10,026,800 | -1.21% |
| 2026-10-02 | $259.38 | $259.38 | $255.12 | $256.03 | 10,940,400 | -1.02% |
| 2026-10-01 | $263.68 | $263.98 | $258.33 | $258.66 | 8,289,000 | -2.30% |
| 2026-09-30 | $267.91 | $268.48 | $264.51 | $264.74 | 6,341,000 | -1.06% |
| 2026-09-29 | $269.11 | $271.89 | $265.59 | $267.57 | 5,620,500 | -1.61% |
| 2026-09-28 | $270.17 | $273.78 | $269.27 | $271.95 | 7,185,600 | +0.27% |
| 2026-09-25 | $271.70 | $272.25 | $269.26 | $271.22 | 4,085,700 | +0.20% |
| 2026-09-24 | $269.52 | $275.23 | $269.01 | $270.68 | 6,320,600 | +0.56% |
| 2026-09-23 | $269.47 | $272.14 | $266.50 | $269.17 | 6,632,700 | -0.01% |
| 2026-09-22 | $267.51 | $270.10 | $265.04 | $269.19 | 5,680,700 | -0.10% |
| 2026-09-21 | $271.74 | $273.73 | $268.50 | $269.47 | 4,485,300 | -0.19% |
| 2026-09-18 | $269.45 | $272.11 | $267.20 | $269.99 | 16,428,400 | -0.09% |
Explore More Analysis for JNJ
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.